Dashboard
Manage Tickers

BGBUNGELTD

NYSE bunge.com


$ 105.22 $ -9.33 (-8.14 %)    

Wednesday, 31-Jul-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.02 $ 13.54 (2.96 %)
DIA $ 408.46 $ 1.08 (0.27 %)
SPY $ 551.56 $ 8.81 (1.63 %)
TLT $ 94.83 $ 0.96 (1.02 %)
GLD $ 226.56 $ 4.03 (1.81 %)
$ 105.23
$ 105.46 x 200
$ 120.00 x 200
-- - --
$ 84.91 - $ 114.92
3,663,973
na
15.29B
$ 0.75
$ 7.79
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-26-2023 09-30-2023 10-Q
2 08-09-2023 06-30-2023 10-Q
3 05-03-2023 03-31-2023 10-Q
4 02-24-2023 12-31-2022 10-K
5 10-26-2022 09-30-2022 10-Q
6 07-27-2022 06-30-2022 10-Q
7 04-27-2022 03-31-2022 10-Q
8 02-24-2022 12-31-2021 10-K
9 10-27-2021 09-30-2021 10-Q
10 07-28-2021 06-30-2021 10-Q
11 05-04-2021 03-31-2021 10-Q
12 02-19-2021 12-31-2020 10-K
13 10-28-2020 09-30-2020 10-Q
14 07-29-2020 06-30-2020 10-Q
15 05-07-2020 03-31-2020 10-Q
16 02-21-2020 12-31-2019 10-K
17 10-30-2019 09-30-2019 10-Q
18 07-31-2019 06-30-2019 10-Q
19 05-08-2019 03-31-2019 10-Q
20 02-22-2019 12-31-2018 10-K
21 10-31-2018 09-30-2018 10-Q
22 08-01-2018 06-30-2018 10-Q
23 05-02-2018 03-31-2018 10-Q
24 02-23-2018 12-31-2017 10-K
25 11-01-2017 09-30-2017 10-Q
26 08-02-2017 06-30-2017 10-Q
27 05-03-2017 03-31-2017 10-Q
28 02-28-2017 12-31-2016 10-K
29 11-02-2016 09-30-2016 10-Q
30 07-28-2016 06-30-2016 10-Q
31 04-28-2016 03-31-2016 10-Q
32 02-25-2016 12-31-2015 10-K
33 11-06-2015 09-30-2015 10-Q
34 07-31-2015 06-30-2015 10-Q
35 04-30-2015 03-31-2015 10-Q
36 03-02-2015 12-31-2014 10-K
37 11-07-2014 09-30-2014 10-Q
38 07-31-2014 06-30-2014 10-Q
39 05-06-2014 03-31-2014 10-Q
40 02-28-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bunge-shares-tumble-over-6-after-q2-miss-ceo-highlights-strategic-moves-amid-cash-flow-concerns
Bunge Shares Tumble Over 6% After Q2 Miss;...
07/31/2024 13:16:50

Bunge shares fall after Q2 results miss estimates; CEO emphasizes progress on strategic goals amid cash flow issues and debt co...

bunge-cfo-predicts-50-drop-in-capex-for-2026-compared-to-2025-excluding-viterra-merger
Bunge CFO Predicts 50% Drop In Capex For 2...
07/31/2024 12:42:36

- Conference Call

correction-bunge-q2-2024-adj-eps-173-misses-180-estimate-sales-13241b-miss-14273b-estimate
CORRECTION: Bunge Q2 2024 Adj. EPS $1.73 M...
07/31/2024 10:49:06

Bunge (NYSE:BG) reported quarterly earnings of $1.73 per share which missed the analyst consensus estimate of $1.80 by 3.89 per...

bunge-sees-fy24-adj-eps-of-925-vs-946-est
Bunge Sees FY24 Adj EPS Of $9.25 Vs. $9.46...
07/31/2024 10:07:32

bunge-and-glencore-backed-viterra-offered-to-divest-assets-in-two-european-countries-to-address-eu-antitrust-concerns-about-34b-deal
Bunge And Glencore-Backed Viterra Offered ...
07/12/2024 15:51:43

- Reuters Citing Sources

bunges-8b-deal-for-viterra-said-to-face-risk-of-delays
Bunge's $8B Deal For Viterra Said To Face ...
07/11/2024 17:22:14

- Bloomberg 

bp-stumbles-weak-oil-trading-refining-margins-drag-down-q2-outlook
BP Stumbles: Weak Oil Trading, Refining Ma...
07/09/2024 09:50:10

BP disclosed weak oil trading results for Q2, with favorable impacts in Upstream production and operations but adverse impacts ...

sas-competition-tribunal-approved-proposed-merger-wherein-bunge-global-sa-intends-to-acquire-viterra-limited-with-condition
SA's Competition Tribunal Approved Propose...
07/03/2024 15:50:55

- Reuters 

bp-eyes-biofuel-dominance-in-brazil-with-expansion-plans-report
BP Eyes Biofuel Dominance In Brazil With E...
06/24/2024 10:58:10

BP plans to expand and diversify its biofuel operations in Brazil, including reported plans for exploring second-generation eth...

bp-doubles-down-on-biofuels-buys-out-bunge-bioenergia-for-14b
BP Doubles Down On Biofuels: Buys Out Bung...
06/20/2024 15:54:32

BP to acquire Bunge's 50% stake in joint venture for $1.4 billion, consolidating financial results and supporting growth in...

Core News & Articles
Bunge Global Has Agreed To Sell Its 50% Sh...
06/20/2024 11:34:31

BP Bunge Bioenergia, a joint venture formed in 2019, combined both companies' Brazilian bioenergy and sugarcane ethanol bus...

paraguays-delayed-soy-exports-hit-113m-t-in-may-up-34-vs-month-earlier
Paraguay's Delayed Soy Exports Hit 1.13M T...
06/11/2024 14:12:03

- Data Shared With Reuters

bunge-says-loading-ops-at-rio-grande-port-resumed-soy-crushing-unit-could-go-back-online-by-end-of-week
Bunge Says Loading Ops At Rio Grande Port ...
05/20/2024 19:50:21

- Statement

bunges-brazil-unit-gradually-resuming-operations-in-rio-grande-says-rio-grande-facilities-not-directly-impacted-by-floods
Bunge's Brazil Unit Gradually Resuming Ope...
05/20/2024 19:49:21

- Statement

bunge-on-516-raised-dividend-from-06625-to-068
Bunge On 5/16 Raised Dividend From $0.6625...
05/16/2024 18:31:37

citigroup-maintains-buy-on-bunge-global-raises-price-target-to-122
Citigroup Maintains Buy on Bunge Global, R...
04/25/2024 22:37:22

Citigroup analyst Thomas Palmer maintains Bunge Global (NYSE:BG) with a Buy and raises the price target from $117 to $122.

bunge-shares-dip-over-5-after-q1-results-details-here
Bunge Shares Dip Over 5% After Q1 Results:...
04/24/2024 13:32:36

Bunge reports Q1 earnings beat but misses revenue estimates, citing mixed performance in agribusiness units; maintains full-yea...

bunge-sees-fy24-adj-eps-of-900-vs-939-est
Bunge Sees FY24 Adj EPS Of $9.00 Vs. $9.39...
04/24/2024 10:04:22

bunge-q1-adj-304-beats-253-estimate-sales-1342b-miss-1396b-estimate
Bunge Q1 Adj $3.04 Beats $2.53 Estimate, S...
04/24/2024 10:02:41

Bunge (NYSE:BG) reported quarterly adjusted earnings of $3.04 per share which beat the analyst consensus estimate of $2.53 by 2...

bunge-names-leaders-for-operations-post-viterra-merger
Bunge Names Leaders For Operations Post Vi...
04/16/2024 14:00:21

Bunge Global reveals leadership appointments post-merger, emphasizing a strategic blend of expertise. Led by CEO Greg Heckman a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)